Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township
- PMID: 23104749
- PMCID: PMC3699204
- DOI: 10.1258/ijsa.2009.009378
Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township
Abstract
We assessed the potential for anticipated changes in sexual risk-taking behaviour following hypothetical administration of a low-efficacy preventive HIV vaccine. We developed a survey and collected self-reported data from 158 HIV-negative volunteers in a cohort undergoing prescreening for Phase I/II HIV vaccine trials in Soweto. Overall, 22% reported they might use condoms less frequently; 9% reported that they might increase their frequency of sex with casual/anonymous partners; and 55% reported their sexual partners might want to use condoms less frequently knowing they were vaccinated. Multivariate analyses revealed that anticipated decrease in condom use was predicted by poor comprehension and by young age. Individuals may increase their risk-taking behaviour knowing that a vaccine would provide only incomplete protection against HIV transmission. In HIV vaccine trials and future vaccination programmes, education and risk-reduction counselling will be needed for vaccinated individuals and their partners, and mass media education campaigns may be necessary.
Similar articles
-
Sexual risk behaviour of the first cohort undergoing screening for enrollment into Phase I/II HIV vaccine trials in South Africa.Int J STD AIDS. 2009 Feb;20(2):95-101. doi: 10.1258/ijsa.2008.008207. Int J STD AIDS. 2009. PMID: 19182054 Free PMC article.
-
Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example.J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):78-90. doi: 10.1097/QAI.0b013e31812506fd. J Acquir Immune Defic Syndr. 2007. PMID: 17589368 Free PMC article.
-
"I am aware of the risks, I am not changing my behaviour": risky sexual behaviour of university students in a high-HIV context.Afr J AIDS Res. 2019 Sep;18(3):244-253. doi: 10.2989/16085906.2019.1655075. Afr J AIDS Res. 2019. PMID: 31575340
-
Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination.AIDS Care. 2015;27(8):1000-4. doi: 10.1080/09540121.2015.1017443. Epub 2015 Mar 2. AIDS Care. 2015. PMID: 25730519 Free PMC article.
-
The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results.Vaccine. 2011 Aug 18;29(36):6107-12. doi: 10.1016/j.vaccine.2011.06.076. Epub 2011 Jul 5. Vaccine. 2011. PMID: 21736912 Free PMC article.
Cited by
-
Sexual Behaviours and Practices before and after Phase I/II HIV Vaccine Trial: A Qualitative Study among Volunteers in Dar es Salaam Tanzania.Int J Environ Res Public Health. 2020 Oct 1;17(19):7193. doi: 10.3390/ijerph17197193. Int J Environ Res Public Health. 2020. PMID: 33019597 Free PMC article. Clinical Trial.
-
Enhancers and barriers to uptake of male circumcision services in Northern Uganda: a qualitative study.AIDS Care. 2020 Aug;32(8):1061-1068. doi: 10.1080/09540121.2019.1698703. Epub 2019 Dec 4. AIDS Care. 2020. PMID: 31795737 Free PMC article.
-
Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012.BMC Public Health. 2016 Apr 14;16:330. doi: 10.1186/s12889-016-2959-3. BMC Public Health. 2016. PMID: 27079900 Free PMC article.
-
A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda.BMC Public Health. 2016 Jan 5;16:7. doi: 10.1186/s12889-015-2668-3. BMC Public Health. 2016. PMID: 26727935 Free PMC article.
References
-
- International AIDS Vaccine Initiative. [last checked 25 August 2009];Database of AIDS Vaccines in Human Trial. 2009 Aug 24; See http://www.iavireport.org/trials-db/Pages/default.aspx.
-
- Garber DA, Silvestri G, Feinberg MB. Prospects for an AIDS vaccine: three big questions, no easy answers. Lancet Infect Dis. 2004;4:397–413. - PubMed
-
- Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr. 2004;37:1393–1403. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
